The effect of monoclonal antibodies against TNFα on cytokine levels in ulcerative gastritis in horses
Open Access
- 19 August 2026
- journal article
- Published by Saint-Petersburg State University of Veterinary Medicine in International Journal of Veterinary Medicine
- No. 2,p. 233-238
Abstract
Equine gastric ulcer disease is a widespread condition affecting up to 90% of sport horses, characterised by erosive lesions of the gastric mucosa and chronic inflammation. Standard therapy with proton pump inhibitors (omeprazole) reduces gastric acidity but does not address the underlying immune dysregulation driving disease chronicity. An imbalance of cytokines — elevated pro-inflammatory mediators (tumour necrosis factor alpha — TNFα, interleukin-1β — IL-1β, interleukin-6 — IL-6) alongside reduced anti-inflammatory signals (interleukin-4 — IL-4, interleukin-10 — IL-10) — is considered a key pathogenic mechanism. The aim of this study was to evaluate the efficacy of targeted anti-cytokine therapy with antiTNFα monoclonal antibodies as an adjunct to standard gastric ulcer disease treatment. Thirty horses with endoscopically confirmed gastric ulcer disease were divided into a control group (omeprazole 4 mg/kg/24 h, n=15) and a study group (omeprazole 4 mg/kg/24 h plus a single intravenous infusion of anti-TNFα monoclonal antibodies 5 mg/kg, n=15). Serum cytokine levels (TNFα, IL-1β, IL-6, IL-4, IL-10) were measured by enzyme-linked immunosorbent assay (ELISA) at baseline, 6 h, 24 h, and 8 days. In the study group, rapid and pronounced suppression of pro-inflammatory cytokines was recorded: TNFα decreased by 96% at 24 h, IL-1β by 82%, and IL-6 by 80% (p < 0.001). Simultaneously, anti-inflammatory responses increased: IL-4 and IL-10 rose by 75% and 68%, respectively, by day 8. The TNFα/IL-10 ratio declined 50-fold, indicating restoration of immune homeostasis. No significant cytokine dynamics were observed in the control group. Targeted anticytokine therapy with anti-TNFα monoclonal antibodies represents a promising immunomodulatory approach to gastric ulcer disease treatment, addressing an existing therapeutic gap.Keywords
This publication has 15 references indexed in Scilit:
- Assessing the inflammatory response in horses undergoing gastric ulceration using salivary ADA and S100A12 as biomarkersResearch in Veterinary Science, 2025
- The efect of phytometabiotic "Phytolysat Gastro" on parameters gomeostaza and changes in the populations of the microfora of the large intestine of calves with gastrointestinal disease syndromeBulletin of NSAU (Novosibirsk State Agrarian University), 2024
- A Comparison of the Efficacy of Two Omeprazole Formulations in the Treatment of Equine Gastric Ulcer Syndrome in Racehorses: A Blinded, Randomized Clinical TrialJournal of Equine Veterinary Science, 2023
- Multiple Cytokine Profiling: A New Model to Predict Response to Tumor Necrosis Factor Antagonists in Ulcerative Colitis PatientsInflammatory Bowel Diseases, 2018
- PREVALENCE AND STRUCTURE OF GASTROINTESTINAL DISEASES OF CALVES IN CONDITIONS OF CASPIAN REGIONInternational Journal of Applied and Fundamental Research (Международный журнал прикладных и фундаментальных исследований), 2018
- European College of Equine Internal Medicine Consensus Statement—Equine Gastric Ulcer Syndrome in Adult HorsesJournal of Veterinary Internal Medicine, 2015
- Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3− Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor TherapyInflammatory Bowel Diseases, 2015
- Gastritis, Enteritis, and Colitis in HorsesVeterinary Clinics of North America: Equine Practice, 2015
- Regenerative Wound Healing: The Role of Interleukin-10Advances in Wound Care, 2014
- Fluid therapy in horses with gastrointestinal diseaseVeterinary Clinics of North America: Equine Practice, 2003